|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001721,
umls-concept:C0009528,
umls-concept:C0014442,
umls-concept:C0018183,
umls-concept:C0018830,
umls-concept:C0030685,
umls-concept:C0239307,
umls-concept:C0391871,
umls-concept:C0392756,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1522408,
umls-concept:C1697272,
umls-concept:C1704806,
umls-concept:C1963578,
umls-concept:C2603343
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1997-6-12
|
|
pubmed:abstractText |
This study was carried out to: (a) compare complement and granulocyte activation during cardiac operations in patients operated with cardiopulmonary bypass coated with heparin by the Duraflo II method, with activation in patients operated with uncoated circuits; and (b) relate complement, and granulocyte activation to selected adverse effects.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1010-7940
|
|
pubmed:author |
pubmed-author:BrockmeierVV,
pubmed-author:DregelidEE,
pubmed-author:FossaAA,
pubmed-author:HadaRR,
pubmed-author:HagmarPP,
pubmed-author:HaldénEE,
pubmed-author:JansenPP,
pubmed-author:MoelMM,
pubmed-author:MohlHH,
pubmed-author:MollnesT ETE,
pubmed-author:PedersenTT,
pubmed-author:SvennevigJ LJL,
pubmed-author:ThelinSS,
pubmed-author:VengePP,
pubmed-author:VidemVV
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
320-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9080162-Aged,
pubmed-meshheading:9080162-Cardiopulmonary Bypass,
pubmed-meshheading:9080162-Complement Activation,
pubmed-meshheading:9080162-Complement Membrane Attack Complex,
pubmed-meshheading:9080162-Coronary Artery Bypass,
pubmed-meshheading:9080162-Europe,
pubmed-meshheading:9080162-Female,
pubmed-meshheading:9080162-Granulocytes,
pubmed-meshheading:9080162-Heparin,
pubmed-meshheading:9080162-Humans,
pubmed-meshheading:9080162-Intraoperative Complications,
pubmed-meshheading:9080162-Lactoferrin,
pubmed-meshheading:9080162-Male,
pubmed-meshheading:9080162-Middle Aged,
pubmed-meshheading:9080162-Myocardial Infarction,
pubmed-meshheading:9080162-Peroxidase,
pubmed-meshheading:9080162-Risk Factors,
pubmed-meshheading:9080162-Surface Properties
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
|
|
pubmed:affiliation |
Department of Thoracic Surgery and Anaesthesiology, Ullevaal Hospital, Oslo, Norway.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
